Orbimed Advisors LLC Novavax Inc Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $6.13 Million - $9.94 Million	-45,580 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $27.5 Million - $41.9 Million	-154,715 Reduced 77.24%	45,580 $9.45 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $5.38 Million - $11.5 Million	44,462 Added 28.53%	200,295 $42.5 Million
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $17.6 Million - $49.9 Million	155,833 New	155,833 $28.3 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.